Atlas Trials

Safety Study Of N-Acetylcysteine For Prevention Of Contrast Induced Nephropathy In Patients w/Stage 3 Renal Failure

Clinical trial NCT00575419 · TERMINATED

Trial details

NCT number
NCT00575419
Sponsor
Oregon Health and Science University
Status
TERMINATED
Phase
Phase 1
Study type
INTERVENTIONAL
Contrast Induced Nephropathy
Start date
2007-11-01
Primary completion
2014-09-15
Enrollment
6

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.